The "technoscientization" of medicine and its limits: Technoscientific identities, biosocialities, and rare disease patient organizations

Poiesis und Praxis

Volumn 8, Issue 2-3, 2011, Pages 67-82

  Wehling, Peter ^a  

^a UNIVERSITY OF AUGSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 83055186483     PISSN: 16156609     EISSN: 16156617     Source Type: Journal    
DOI: 10.1007/s10202-011-0100-3     Document Type: Article

References (40)

1. Atkinson P, Glasner P, Greenslade H (eds) (2007) New genetics, new identities. Routledge, London.
2. Barker K (2002) Self-help literature and the making of an illness identity: the case of fibromyalgia syndrome (FMS). Soc Probl 49: 279-300.
3. Bharadwaj A, Atkinson P, Clarke A (2007) Medical classification and the experience of genetic haematochromatosis. In: Atkinson P, Glasner P, Greenslade H (eds) New genetics, new identities. Routledge, London.
4. Burri R, Dumit J (eds) (2007) Biomedicine as culture: instrumental practices, technoscientific knowledge, and new modes of life. Routledge, London.
5. Callon M, Rabeharisoa V (2003) Research "in the wild" and the shaping of new social identities. Technol Soc 24: 193-204.
6. Callon M, Rabeharisoa V (2008) The growing engagement of emergent concerned groups in political and economic life. Lessons from the French association of neuromuscular disease patients. Sci Technol Human Values 33: 230-261.
7. Clarke A, Shim J, Mamo L, Fosket JR, Fishman J (2003) Biomedicalization: technoscientific transformations of health, illness, and U. S. biomedicine. Am J Sociol 68: 161-194.
8. Clarke A, Shim J, Shostak S, Nelson A (2009) Biomedicalising genetic health, diseases and identities. In: Atkinson P, Glasner P, Lock M (eds) Handbook of genetics and society. Mapping the new genomic era. Routledge, London, pp 21-40.
9. Clarke A, Mamo L, Fosket JR, Fishman J, Shim J (2010a) Biomedicalization: technoscience, health and illness in the US. Duke University Press, Durham.
10. Clarke A, Shim J, Mamo L, Fosket JR, Fishman J (2010b) Biomedicalization: a theoretical and substantive introduction. In: Clarke A, Mamo L, Fosket JR, Fishman J, Shim J (eds) Biomedicalization: technoscience, health and illness in the U. S. Duke University Press, Durham, pp 1-44.
11. Conrad P (2007) The medicalization of society: on the transformation of human conditions into treatable disorders. Johns Hopkins University Press, Baltimore.
12. Epstein S (2008) Patient groups and health movements. In Hackett EJ et al. (eds) The handbook of science and technology studies, 3rd edn. MIT Press, Cambridge, pp 499-539.
13. Fosket JR (2004) Constructing "High-Risk-Women": the development and standardization of a breast cancer risk assessment tool. Sci Technol Human Values 29: 291-313.
14. Fosket JR (2010) Breast cancer risk as disease. Biomedicalizing risk. In: Clarke A, Mamo L, Fosket JR, Fishman J, Shim J (eds) Biomedicalization: technoscience, health and illness in the U. S. Duke University Press, Durham, pp 331-352.
15. Gibbon S, Novas C (eds) (2008) Biosocialities, genetics and the social sciences: making biologies and identities. Routledge, London.
16. Hughes B (2009) Disability activisms: social model stalwarts and biological citizens. Disabil Soc 24: 677-688.
17. Huyard C (2009a) How did uncommon disorders become 'rare diseases'? History of a boundary object. Sociol Health Illn 31(4): 463-477.
18. Huyard C (2009b) What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare. Health Expect 12: 361-370.
19. Kollek R, Lemke Th (2008) Der medizinische Blick in die Zukunft. Gesellschaftliche Folgen prädiktiver Gentests. Campus, Frankfurt am Main.
20. Langstrup H (2011) Interpellating patients as users: patient associations and the project-ness of stem cell research. Sci Technol Human Values 36: 573-594.
21. Lemke Th (2004) Veranlagung und Verantwortung. Genetische Diagnostik zwischen Selbstbestimmung und Schicksal. Transcript, Bielefeld.
22. Lemke Th (2006) Die Polizei der Gene. Formen und Felder genetischer Diskriminierung. Campus, Frankfurt am Main.
23. Lemke Th (2010) Neue Vergemeinschaftungen? Entstehungskonzepte, Rezeptionslinien und Entwicklungstendenzen des Konzepts der Biosozialität. In: Liebsch K, Manz U (eds) Leben mit den Lebenswissenschaften. Wie wird biomedizinisches Wissen in Alltagspraxen übersetzt? Transcript, Bielefeld, pp 21-41.
24. Lemke Th, Wehling P (2009) Bürgerrechte durch Biologie? Kritische Anmerkungen zur Konjunktur des Konzepts 'biologische Bürgerschaft'. In: Weiß M (ed) Bios und Zoe. Die menschliche Natur im Zeitalter ihrer technischen Reproduzierbarkeit. Suhrkamp, Frankfurt am Main, pp 72-107.
25. Mathar Th (2010) Der digitale Patient. Zu den Konsequenzen eines technowissenschaftlichen Gesundheitssystems. Transcript, Bielefeld.
26. Mol A (2008) The logic of care. Health and the problem of patient choice. Routledge, London.
27. Novas C (2007) Genetic advocacy groups, science and biovalue: creating political economies of hope. In: Atkinson P, Glasner P, Greenslade H (eds) New genetics, new identities. Routledge, London, pp 11-27.
28. Panofsky A (2011) Generating sociability to drive science: patient advocacy organizations and genetics research. Social Stud Sci 41(1): 31-57.
29. Rabinow P (1996) Essays on the anthropology of reason. Princeton University Press, Princeton.
30. Rabinow P (2008) Afterword: concept work. In: Gibbon S, Novas C (eds) Biosocialities, genetics and the social sciences: making biologies and identities. Routledge, London, pp 188-192.
31. Rose N (2007) The politics of life itself: biomedicine, power, and subjectivity in the twenty-first century. Princeton University Press, Princeton.
32. Stockdale A (1999) Waiting for the cure: mapping the social relations of human gene therapy research. Sociol Health Illn 21(5): 579-596.
33. Stockdale A, Terry S (2002) Advocacy groups and the new genetics. In: Alper J et al. (eds) The double-edged helix. Social implications of genetics in a diverse society. Johns Hopkins UP, Baltimore, pp 80-101.
34. Sulik G (2009) Managing biomedical uncertainty: the technoscientific illness identity. Sociol Health Illn 31(7): 1059-1076.
35. Sulik G (2011) 'Our Diagnoses, Our Selves': the rise of the technoscientific illness identity. Sociol Compass 5: 463-477.
36. Taussig K, Rapp R, Heath D (2003) Flexible eugenics: technologies of the self in the age of genetics. In: Goodman AH, Heath D, Lindee SM (eds) Genetic nature/culture. University of California Press, Berkeley, pp 58-76.
37. Terry SF, Terry PF, Rauen KA, Uitto J, Bercovitch LG (2007) Advocacy groups as research organizations: the PXE international example. Nat Rev Genet 8(2): 157-164.
38. Wailoo K, Pemberton S (2006) The troubled dream of genetic medicine. Johns Hopkins UP, Baltimore.
39. Wehling P (2011) Biology, citizenship and the government of biomedicine: Exploring the concept of biological citizenship. In: Bröckling U, Krasmann S, Lemke Th (eds) Governmentality-current debates and future issues. Routledge, New York, pp 225-246.
40. Wehling P, Viehöver W (2011) Entgrenzung der Medizin: Transformationen des medizinischen Feldes aus soziologischer Perspektive. In: Viehöver W, Wehling P (eds) Entgrenzung der Medizin: Von der Heilkunst zur Verbesserung des Menschen? Transcript, Bielefeld, pp 7-47.